January 26th 2023
Based on their findings, an international team of researchers is discouraging the application of atropine as a standard therapy for trabeculectomy surgery.
September 28th 2022
Nicox’s NCX 470 Dolomites Phase 2 results published in Journal of Glaucoma
April 11th 2022NCX 470 is currently enrolling patients in two multi-regional Phase 3 glaucoma clinical trials, Mont Blanc and Denali. The objective of these two trials is to demonstrate statistically superior IOP lowering of once daily dosed NCX 470
Read More
Micro-bypass stent implant during cataract surgery: lower IOP, fewer medications
July 25th 2021Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.
Read More